- Home
- LILAK vs CMPS Comparison
LILAK vs CMPS Comparison
Compare LILAK & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LILAK | CMPS |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LILAK | CMPS |
|---|---|---|
| Price | $8.68 | $14.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $8.20 | ★ $25.38 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.55 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,442,200,000.00 | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.75 | $4.82 |
| 52 Week High | $9.13 | $15.87 |
Technical Indicators
Market Signals| Indicator | LILAK | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 59.29 | 54.42 |
| Support Level | $7.38 | $13.07 |
| Resistance Level | $8.93 | $14.87 |
| Average True Range (ATR) | 0.25 | 0.78 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 94.59 | 44.99 |
Price Performance
Historical ComparisonAbout LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.